| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 2134 | 2018 |
| A pan-cancer proteogenomic atlas of PI3K/AKT/mTOR pathway alterations Y Zhang, PKS Ng, M Kucherlapati, F Chen, Y Liu, YH Tsang, ... Cancer cell 31 (6), 820-832. e3, 2017 | 511 | 2017 |
| The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers L Han, L Diao, S Yu, X Xu, J Li, R Zhang, Y Yang, HMJ Werner, ... Cancer cell 28 (4), 515-528, 2015 | 473 | 2015 |
| Comprehensive molecular characterization of the hippo signaling pathway in cancer Y Wang, X Xu, D Maglic, MT Dill, K Mojumdar, PKS Ng, KJ Jeong, ... Cell reports 25 (5), 1304-1317. e5, 2018 | 354 | 2018 |
| Verteporfin inhibits YAP function through up-regulating 14-3-3σ sequestering YAP in the cytoplasm C Wang, X Zhu, W Feng, Y Yu, K Jeong, W Guo, Y Lu, GB Mills American journal of cancer research 6 (1), 27, 2016 | 286 | 2016 |
| Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer SY Park, J Jun, KJ Jeong, HJ Heo, JS Sohn, HY Lee, CG Park, J Kang Oncology reports 25 (6), 1677-1681, 2011 | 247 | 2011 |
| Systematic functional annotation of somatic mutations in cancer PKS Ng, J Li, KJ Jeong, S Shao, H Chen, YH Tsang, S Sengupta, Z Wang, ... Cancer cell 33 (3), 450-462. e10, 2018 | 243 | 2018 |
| BRD4 inhibition is synthetic lethal with PARP inhibitors through the induction of homologous recombination deficiency C Sun, J Yin, Y Fang, J Chen, KJ Jeong, X Chen, CP Vellano, Z Ju, ... Cancer cell 33 (3), 401-416. e8, 2018 | 242 | 2018 |
| Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers C Sun, Y Fang, J Yin, J Chen, Z Ju, D Zhang, X Chen, CP Vellano, ... Science translational medicine 9 (392), eaal5148, 2017 | 197 | 2017 |
| Sequential therapy with PARP and WEE1 inhibitors minimizes toxicity while maintaining efficacy Y Fang, DJ McGrail, C Sun, M Labrie, X Chen, D Zhang, Z Ju, CP Vellano, ... Cancer cell 35 (6), 851-867. e7, 2019 | 180 | 2019 |
| A-to-I RNA editing contributes to proteomic diversity in cancer X Peng, X Xu, Y Wang, DH Hawke, S Yu, L Han, Z Zhou, K Mojumdar, ... Cancer cell 33 (5), 817-828. e7, 2018 | 180 | 2018 |
| Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression SY Park, KJ Jeong, N Panupinthu, S Yu, J Lee, JW Han, JM Kim, JS Lee, ... Oncogene 30 (11), 1351-1359, 2011 | 166 | 2011 |
| Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers Y Wang, X Xu, S Yu, KJ Jeong, Z Zhou, L Han, YH Tsang, J Li, H Chen, ... Genome research 27 (7), 1112-1125, 2017 | 162 | 2017 |
| The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion KJ Jeong, SY Park, KH Cho, JS Sohn, J Lee, YK Kim, J Kang, CG Park, ... Oncogene 31 (39), 4279-4289, 2012 | 141 | 2012 |
| Hypoxia enhances LPA-induced HIF-1α and VEGF expression: Their inhibition by resveratrol SY Park, KJ Jeong, J Lee, DS Yoon, WS Choi, YK Kim, JW Han, YM Kim, ... Cancer Letters 258 (1), 63-69, 2007 | 127 | 2007 |
| STAT3 mediates TGF-β1-induced TWIST1 expression and prostate cancer invasion KH Cho, KJ Jeong, SC Shin, J Kang, CG Park, HY Lee Cancer letters 336 (1), 167-173, 2013 | 120 | 2013 |
| Lysophosphatidic acid induces STAT3 phosphorylation and ovarian cancer cell motility: their inhibition by curcumin JH Seo, KJ Jeong, WJ Oh, HJ Sul, JS Sohn, YK Kim, JK Kang, CG Park, ... Cancer letters 288 (1), 50-56, 2010 | 116 | 2010 |
| A ROS/STAT3/HIF‐1α signaling cascade mediates EGF‐induced TWIST1 expression and prostate cancer cell invasion KH Cho, MJ Choi, KJ Jeong, JJ Kim, MH Hwang, SC Shin, CG Park, ... The Prostate 74 (5), 528-536, 2014 | 100 | 2014 |
| Direct upregulation of STAT3 by microRNA-551b-3p deregulates growth and metastasis of ovarian cancer P Chaluvally-Raghavan, KJ Jeong, S Pradeep, AM Silva, S Yu, W Liu, ... Cell reports 15 (7), 1493-1504, 2016 | 84 | 2016 |
| hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness MJ Choi, KH Cho, S Lee, YJ Bae, KJ Jeong, SY Rha, EJ Choi, JH Park, ... Oncogene 34 (26), 3402-3412, 2015 | 78 | 2015 |
